Genetically Modified Marmosets

CRISPR-Cas9 first creates a targeted break in DNA, after which the cell’s repair process determines the resulting genetic change. Researchers can use that repair event to disrupt an existing sequence, replace it with another sequence, or insert a new one. In genetically modified marmosets, this provides a way to investigate how a selected gene contributes to biological processes or disease-related traits.

Transgene introduction and CRISPR-Cas9 provide different routes to genetic modification. A transgene adds a deliberately selected genetic sequence, whereas CRISPR-Cas9 acts through a targeted DNA break whose repair can disrupt, replace, or insert sequence. This distinction lets researchers choose between studying the effects of an introduced gene and examining the consequences of a more specifically directed genomic change.

The timing matters because the described genetic change is made during early embryonic development, when DNA repair determines whether the intended disruption, replacement, or insertion is established as the organism develops. Focusing the intervention at this stage connects the molecular edit to the later biology of the marmoset, allowing researchers to examine resulting disease or physiological traits in the developing organism.

Their value comes from combining experimental genetic alteration with primate physiology and behavior that are relevant to humans. This makes them useful as an intermediate research context between rodent findings and clinical research. The model can therefore help investigators determine whether observations made in rodents remain informative when examined in a species with more human-relevant biological and behavioral features.

Applications include inherited disorders, neurological conditions, infectious diseases, and other human-relevant traits. By altering a selected gene or sequence and observing the resulting traits, researchers can investigate disease mechanisms rather than only describe symptoms. The same models may also support evaluation of potential therapies, linking gene function studies with clinically oriented research.

Careful ethical oversight is required because this research deliberately changes the DNA of nonhuman primates for biological investigation. The requirement is not separate from the science: it frames how genetically modified marmosets are used to study disease, biological processes, and possible therapies. Ethical review is therefore a necessary part of applying these models responsibly in biology.